The Consistency and Transferability of Economic Evaluations of Disease-Modifying Treatments for Multiple Sclerosis: Analysis of Cost-Effectiveness Assessments from Australia, England, Canada and Scotland
This study highlighted the consistency of the economic evaluation for DMTs within the four agencies. We also identified a particularly strong alignment between NICE and the CDA, as well as the PBAC and SMC. Additionally, the examination of two ICER value conversion methods pinpointed key factors that could impact the transference of ICER values.
Authors
- David Newby (ORCID: https://orcid.org/0000-0002-6818-6636)
- Shu Chuen Li (ORCID: https://orcid.org/0000-0002-3329-3095)
- Fei-Li Zhao (ORCID: https://orcid.org/0000-0001-5279-5595)
- Lan Gao (ORCID: https://orcid.org/0000-0001-9734-1140)
- Xiang Ming Wang (ORCID: https://orcid.org/0000-0002-0221-8404)
Institutions
- Deakin University (AU)
- University of Newcastle Australia (AU)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1007/s41669-025-00606-x
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00